Alcresta

About:

Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.

Website: http://alcresta.com

Top Investors: Bessemer Venture Partners, Frazier Healthcare Partners, Third Rock Ventures, HealthQuest Capital

Description:

Alcresta is developing and commercializing innovative, point-of-care, enzyme-based nutritional products that support improved nutrition and manage disease for infants, aging adults and people battling acute conditions or chronic diseases. Alcresta’s research-based approach is innovative, proprietary and driven by the unmet nutritional needs of those people with compromised health. Alcresta’s core capabilities include expertise in adult and pediatric nutrition, as well as protein manufacturing expertise and regulatory experience that support the development and commercialization of its programs. The company’s platform is supported by the Alcresta team’s proven success in developing protein therapeutics.

Total Funding Amount:

$139M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Newton, Massachusetts, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)alcresta.com

Founders:

Robert Gallotto, Shaheda Ahmed

Number of Employees:

11-50

Last Funding Date:

2020-02-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai